1. Home
  2. FEIM vs OPTN Comparison

FEIM vs OPTN Comparison

Compare FEIM & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • OPTN
  • Stock Information
  • Founded
  • FEIM 1961
  • OPTN 2010
  • Country
  • FEIM United States
  • OPTN United States
  • Employees
  • FEIM N/A
  • OPTN N/A
  • Industry
  • FEIM Electrical Products
  • OPTN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • OPTN Health Care
  • Exchange
  • FEIM Nasdaq
  • OPTN Nasdaq
  • Market Cap
  • FEIM 119.5M
  • OPTN 117.6M
  • IPO Year
  • FEIM N/A
  • OPTN 2017
  • Fundamental
  • Price
  • FEIM $12.06
  • OPTN $0.71
  • Analyst Decision
  • FEIM
  • OPTN Strong Buy
  • Analyst Count
  • FEIM 0
  • OPTN 2
  • Target Price
  • FEIM N/A
  • OPTN $4.00
  • AVG Volume (30 Days)
  • FEIM 64.5K
  • OPTN 517.4K
  • Earning Date
  • FEIM 09-10-2024
  • OPTN 11-07-2024
  • Dividend Yield
  • FEIM 8.29%
  • OPTN N/A
  • EPS Growth
  • FEIM N/A
  • OPTN N/A
  • EPS
  • FEIM 0.62
  • OPTN N/A
  • Revenue
  • FEIM $57,943,000.00
  • OPTN $75,058,000.00
  • Revenue This Year
  • FEIM N/A
  • OPTN $24.44
  • Revenue Next Year
  • FEIM N/A
  • OPTN $49.00
  • P/E Ratio
  • FEIM $19.41
  • OPTN N/A
  • Revenue Growth
  • FEIM 28.82
  • OPTN 3.91
  • 52 Week Low
  • FEIM $6.93
  • OPTN $0.65
  • 52 Week High
  • FEIM $14.50
  • OPTN $2.10
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 43.27
  • OPTN 33.40
  • Support Level
  • FEIM $11.90
  • OPTN $0.65
  • Resistance Level
  • FEIM $12.46
  • OPTN $0.70
  • Average True Range (ATR)
  • FEIM 0.34
  • OPTN 0.05
  • MACD
  • FEIM -0.02
  • OPTN -0.00
  • Stochastic Oscillator
  • FEIM 39.33
  • OPTN 24.67

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

Share on Social Networks: